NCT05328284

PASCAL for Tricuspid Regurgitation - a European Registry

Name: Clinical Trial NCT05328284
Creator: LMU Klinikum
Keywords: Tricuspid Regurgitation, PASCAL leaflet repair system, device, clinical trial, Germany,Sweden,Switzerland

PASTE: PASCAL for Tricuspid Regurgitation - a European Registry

LMU Klinikum·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Tricuspid Regurgitation
Drug/Device/Intervention: PASCAL leaflet repair system
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: LMU Klinikum
Location: Bad Berka,Bad Oeynhausen,Essen,Hamburg,Hamburg,Heidelberg,Leipzig,Munich,Siegburg,Tuebingen,Ulm,Stockholm,Bern,Luzern, Germany,Sweden,Switzerland

Timeline & enrollment

Phase: N/A
Start date: May 05, 2021
End date: May 30, 2024
Enrollment: 1000 participants

Primary outcome

Change of TR severity

Summary

This study aims to investigate the safety and efficacy of the PASCAL leaflet repair system in the treatment of tricuspid regurgitation in a commercial use setting including all consecutive patients at the participating Centers in an observational fashion.

ICD-10 classifications

Tricuspid stenosisTricuspid stenosis with insufficiencyNonrheumatic tricuspid (valve) stenosisTricuspid insufficiencyNonrheumatic tricuspid (valve) stenosis with insufficiency

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05328284
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05328284 through Pure Global AI's free database. This phase not specified trial is sponsored by LMU Klinikum and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.